{"altmetric_id":4672900,"counts":{"readers":{"mendeley":18,"citeulike":0,"connotea":0},"total":{"posts_count":1},"blogs":{"unique_users_count":1,"unique_users":[55978],"posts_count":1}},"citation":{"altmetric_jid":"4f6fa4ef3cf058f610002cc7","authors":["Md. Suhail Alam","Michelle Getz","Sue Yi","Jeffrey Kurkewich","Innocent Safeukui","Kasturi Haldar"],"doi":"10.1074\/jbc.m113.526392","first_seen_on":"2015-10-26T00:19:22+00:00","funders":["nhlbi"],"issns":["0021-9258","1083-351X"],"journal":"Journal of Biological Chemistry","last_mentioned_on":1445818200,"links":["http:\/\/www.jbc.org\/content\/289\/12\/8051.long"],"pdf_url":"http:\/\/www.jbc.org\/content\/289\/12\/8051.full.pdf","pmid":"24488491","pubdate":"2014-03-21T00:00:00+00:00","publisher_subjects":[{"name":"Biological Sciences","scheme":"era"},{"name":"Medical And Health Sciences","scheme":"era"},{"name":"Chemical Sciences","scheme":"era"}],"scopus_subjects":["Life Sciences","Biochemistry, Genetics and Molecular Biology"],"subjects":["biochemistry"],"title":"Plasma Signature of Neurological Disease in the Monogenetic Disorder Niemann-Pick Type C","type":"article","mendeley_url":"http:\/\/www.mendeley.com\/research\/plasma-signature-neurological-disease-monogenetic-disorder-niemannpick-type-c"},"altmetric_score":{"score":5.504,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":5.504},"context_for_score":{"all":{"total_number_of_other_articles":6491271,"mean":5.9704270061169,"rank":1026652,"this_scored_higher_than_pct":84,"this_scored_higher_than":5464321,"rank_type":"exact","sample_size":6491271,"percentile":84},"similar_age_3m":{"total_number_of_other_articles":208028,"mean":10.081254789042,"rank":45487,"this_scored_higher_than_pct":78,"this_scored_higher_than":162541,"rank_type":"exact","sample_size":208028,"percentile":78},"this_journal":{"total_number_of_other_articles":28976,"mean":3.0624118723037,"rank":1446,"this_scored_higher_than_pct":95,"this_scored_higher_than":27528,"rank_type":"exact","sample_size":28976,"percentile":95},"similar_age_this_journal_3m":{"total_number_of_other_articles":417,"mean":4.1956826923077,"rank":76,"this_scored_higher_than_pct":81,"this_scored_higher_than":341,"rank_type":"exact","sample_size":417,"percentile":81}}},"demographics":{"users":{"mendeley":{"by_status":{"Researcher":7,"Student  > Ph. D. Student":6,"Student  > Master":1,"Other":1,"Student  > Bachelor":2,"Professor":1},"by_discipline":{"Engineering":1,"Medicine and Dentistry":2,"Neuroscience":1,"Psychology":1,"Agricultural and Biological Sciences":9,"Biochemistry, Genetics and Molecular Biology":2,"Unspecified":1,"Veterinary Science and Veterinary Medicine":1}}},"geo":{"mendeley":{"US":2}}},"posts":{"blogs":[{"title":"Biomarkers for NPC diagnosis and therapeutic efficacy","url":"http:\/\/www.plab.co\/blog\/biomarkers-for-npc-diagnosis-and-therapeutic-efficacy\/","license":"public","citation_ids":[4672899,4672900,4179980,4672901,3529980],"posted_on":"2015-10-26T00:10:00+00:00","summary":"Biomarkers for NPC\nHow will investigators, clinicians and patients&nbsp;know if their therapeutic for the treatment of NPC is efficacious? In this blog post we will explore a few of the&nbsp;potential biomarkers that can be used to monitor disease progress","author":{"name":"Perlstein Lab","url":"http:\/\/www.perlsteinlab.com\/","description":"Evolutionary Pharmacology"}}]}}